SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 141 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $393,300 | -85.4% | 15,000 | -85.6% | 0.00% | -86.7% |
| Q1 2023 | $2,687,256 | -3.3% | 104,400 | -2.2% | 0.02% | +7.1% |
| Q4 2022 | $2,777,868 | +549.0% | 106,800 | +612.0% | 0.01% | +600.0% |
| Q3 2022 | $428,000 | +16.0% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $369,000 | -56.4% | 15,000 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $847,000 | -8.9% | 15,000 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $930,000 | -91.2% | 15,000 | -91.0% | 0.00% | -92.3% |
| Q3 2021 | $10,563,000 | +754.6% | 166,500 | +1010.0% | 0.03% | +766.7% |
| Q2 2021 | $1,236,000 | +12.0% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,104,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
| Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
| M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
| Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
| Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
| EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
| Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
| Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
| Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |